Connect Sign In
Genomic sequencing advances have transformed our ability to detect and understand genetic drivers of disease. ARUP’s whole genome sequencing (WGS) facilitates rapid diagnosis and timely intervention.
When Marzia Pasquali, PhD, FACMG, joined ARUP Laboratories in 2001, the state of Utah only included five conditions in its newborn screening program.
For critically ill newborns, swift diagnosis is critical to initiate treatment in time. Rapid whole genome tests sequence the entire genome in days, transforming diagnostic capabilities.
During Cervical Cancer Awareness Month, ARUP Consult® highlights self-collected vaginal specimen testing as an FDA-approved, guideline-supported option to help address HPV screening barriers.
ARUP Laboratories’ dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid assay to aid the public health response to ongoing measles outbreaks.
RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be…
Parasitology had been technologically stagnant for decades until ARUP changed the game. Now, ARUP leverages artificial intelligence (AI) to improve detection of gastrointestinal parasites and ease a laborious testing process.
Hereditary cancer genetic testing is underutilized, despite its benefits. Julie Solimine, MGC, LCGC, aims to raise awareness and adoption of testing by explaining why testing matters and who qualifies for it.
ARUP is the first reference laboratory to offer a molecular measles assay that both detects the measles virus and distinguishes between infection-causing and vaccine strains of the virus.
Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time.
